TJX
62
-3
FOX
64
2
SRE
44
2
VZ
37
-5
WM
57
-2
APA
48
-4
SO
51
3
VNO
50
-2
PHM
43
-3
ETN
53
-2
NEE
52
2
A
48
8
KMI
53
-4
MSFT
46
5
ADP
58
-8
MMC
58
-2
MDLZ
28
6
MS
69
-3
MAR
68
-3
MCHP
55
5
TJX
62
-3
FOX
64
2
SRE
44
2
VZ
37
-5
WM
57
-2
APA
48
-4
SO
51
3
VNO
50
-2
PHM
43
-3
ETN
53
-2
NEE
52
2
A
48
8
KMI
53
-4
MSFT
46
5
ADP
58
-8
MMC
58
-2
MDLZ
28
6
MS
69
-3
MAR
68
-3
MCHP
55
5
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Vs. Insmed, Inc. Industry Stock Comparison

Buy
68

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$40.10
Seasonality Move:
-0.67%
Sell
40

INSM
Insmed, Inc.

Last Price:
$174.52
Seasonality Move:
7.61%
Buy
68
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Buy

Is Virtus LifeSci Biotech Clinical Trials ETF a Buy, Sell or Hold?

  • The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $38.57. The Score for BBC is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • BBC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Insmed, Inc. (INSM) is a Sell

Is Insmed, Inc. a Buy, Sell or Hold?

  • The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BBC Stock Price Chart

What is Virtus LifeSci Biotech Clinical Trials ETF's stock price today?

  • The Virtus LifeSci Biotech Clinical Trials ETF share price today is $38.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.

INSM Stock Price Chart

What is Insmed, Inc.'s stock price today?

  • The Insmed, Inc. share price today is $166.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.

BBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.77 Buy
Relative Strength Index (14 RSI): 60.72 Buy
Chaikin Money Flow: -9708 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.24 - 39.58) Buy
Bollinger Bands (100): (23.06 - 34.66) Buy

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 29.93 Sell
Chaikin Money Flow: -270452 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (190.54 - 208.08) Sell
Bollinger Bands (100): (130.7 - 191.18) Buy

BBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.48 Sell
20-day SMA: 37.92 Buy
50-day SMA: 33.81 Buy
200-day SMA: 23.94 Buy
8-day EMA: 39.04 Sell
20-day EMA: 37.69 Buy
50-day EMA: 34.23 Buy
200-day EMA: 27.21 Buy

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.36 Sell
20-day SMA: 199.79 Sell
50-day SMA: 186.64 Sell
200-day SMA: 121.17 Buy
8-day EMA: 191.25 Sell
20-day EMA: 194.86 Sell
50-day EMA: 184.92 Sell
200-day EMA: 135.61 Buy

Virtus LifeSci Biotech Clinical Trials ETF Earnings Growth & BBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Insmed, Inc. Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and an increase next year of $2.60 per share.

Virtus LifeSci Biotech Clinical Trials ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Insmed, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):